Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Drugs and Chemicals›Neonicotinoids
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Neonicotinoids

Drugs and Chemicals · NLM MeSH · updated 2026-10-31 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 5 min read

A class of insecticides that are structurally similar to nicotine and have physiologically similar effects as agonists of nicotinic acetylcholine receptors, but are less toxic to vertebrates.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (874 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

A class of insecticides that are structurally similar to nicotine and have physiologically similar effects as agonists of nicotinic acetylcholine receptors, but are less toxic to vertebrates. They are widely used in agriculture.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Neonicotinoid.

Where it fits in the MeSH classification

Broader topics
Heterocyclic Compounds, 1-Ring
Narrower topics
Thiamethoxam

Related concepts

  • Nicotine
  • Nicotinic Acetylcholine Receptors

Research landscape

PubMed indexes 5,794 records tagged with the MeSH heading “Neonicotinoids” (counts retrieved 2026-10-31). 3,121 of them (53.9%) were published from 2020 onward, and the busiest period so far is 2020 onward with 3,121 records.

Reviews account for 160 records (2.8%) and meta-analyses for 14. Randomized controlled trials number 74 (1.3%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 0 records; 2000-2009: 631 records; 2010-2019: 2,097 records; 2020 onward: 3,121 records0through 19996312000-20092,0972010-20193,1212020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 19990
2000-2009631
2010-20192,097
2020 onward3,121
Share of records by publication typeReviews: 2.8 percent; Meta-analyses: 0.2 percent; Randomized controlled trials: 1.3 percentReviews2.8% (160)Meta-analyses0.2% (14)Randomized controlled trials1.3% (74)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 5,794 PubMed records
TypeRecordsShare
Reviews1602.8%
Meta-analyses140.2%
Randomized controlled trials741.3%

Method: PubMed query "Neonicotinoids"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-31.

Reading the evidence in drugs and chemicals

Studies of a chemical or drug can answer very different questions: what it is and how it behaves in cells and animals, how the body handles it, and whether it changes outcomes in people. Laboratory and animal findings often do not carry over to patients, and observational studies of exposures are confounded by who uses a substance and why. Nothing on this page is a recommendation to use, avoid, start or stop any substance or medicine; talk to a qualified clinician or pharmacist about your own situation. Check the dose, the species, the comparison group and whether a patient-relevant outcome was measured.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Unravelling the Molecular Determinants of Bee Sensitivity to Neonicotinoid Insecticides
Manjon C, Troczka BJ, Zaworra M, Beadle K, Randall E, Hertlein G, et al.
2018Research article
Design not recorded in structured metadata
242cc by
PMID 29576476 · DOI · PMC5887109
Neofunctionalization of Duplicated P450 Genes Drives the Evolution of Insecticide Resistance in the Brown Planthopper
Zimmer CT, Garrood WT, Singh KS, Randall E, Lueke B, Gutbrod O, et al.
2018Research article
Design not recorded in structured metadata
144cc by
PMID 29337073 · DOI · PMC5788746
Pesticide use negatively affects bumble bees across European landscapes
Nicholson CC, Knapp J, Kiljanek T, Albrecht M, Chauzat MP, Costa C, et al.
2024Research article
Design not recorded in structured metadata
106cc by
PMID 38030722 · DOI · PMC11006599
Neonicotinoid Levels Exceed EPA Benchmarks in Half of Waterways on Illinois Protected Lands
Hohoff TC, Bilger EE, Gieser R, Davis MA
2026Research article
Design not recorded in structured metadata
0cc by
PMID 42622890 · DOI · PMC13493470

Unravelling the Molecular Determinants of Bee Sensitivity to Neonicotinoid Insecticides [1]

Research article Manjon C, Troczka BJ, Zaworra M, Beadle K, Randall E, Hertlein G, et al. · · 2018 · cited 242 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
The impact of neonicotinoid insecticides on the health of bee pollinators is a topic of intensive research and considerable current debate [1].
Closing excerpt
Our results demonstrate that bee pollinators are equipped with biochemical defense systems that define their sensitivity to insecticides and this knowledge can be leveraged to safeguard bee health.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (246 words)

The impact of neonicotinoid insecticides on the health of bee pollinators is a topic of intensive research and considerable current debate [1]. As insecticides, certain neonicotinoids, i.e., N-nitroguanidine compounds such as imidacloprid and thiamethoxam, are as intrinsically toxic to bees as to the insect pests they target. However, this is not the case for all neonicotinoids, with honeybees orders of magnitude less sensitive to N-cyanoamidine compounds such as thiacloprid [2]. Although previous work has suggested that this is due to rapid metabolism of these compounds [2-5], the specific gene(s) or enzyme(s) involved remain unknown. Here, we show that the sensitivity of the two most economically important bee species to neonicotinoids is determined by cytochrome P450s of the CYP9Q subfamily. Radioligand binding and inhibitor assays showed that variation in honeybee sensitivity to N-nitroguanidine and N-cyanoamidine neonicotinoids does not reside in differences in their affinity for the receptor but rather in divergent metabolism by P450s. Functional expression of the entire CYP3 clade of P450s from honeybees identified a single P450, CYP9Q3, that metabolizes thiacloprid with high efficiency but has little activity against imidacloprid. We demonstrate that bumble bees also exhibit profound differences in their sensitivity to different neonicotinoids, and we identify CYP9Q4 as a functional ortholog of honeybee CYP9Q3 and a key metabolic determinant of neonicotinoid sensitivity in this species. Our results demonstrate that bee pollinators are equipped with biochemical defense systems that define their sensitivity to insecticides and this knowledge can be leveraged to safeguard bee health.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 29576476 · DOI · PMC5887109

Neofunctionalization of Duplicated P450 Genes Drives the Evolution of Insecticide Resistance in the Brown Planthopper [2]

Research article Zimmer CT, Garrood WT, Singh KS, Randall E, Lueke B, Gutbrod O, et al. · · 2018 · cited 144 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Gene duplication is a major source of genetic variation that has been shown to underpin the evolution of a wide range of adaptive traits [1, 2].
Closing excerpt
Our findings illustrate the versatility of gene duplication in providing opportunities for functional and regulatory innovation during the evolution of an adaptive trait.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (248 words)

Gene duplication is a major source of genetic variation that has been shown to underpin the evolution of a wide range of adaptive traits [1, 2]. For example, duplication or amplification of genes encoding detoxification enzymes has been shown to play an important role in the evolution of insecticide resistance [3-5]. In this context, gene duplication performs an adaptive function as a result of its effects on gene dosage and not as a source of functional novelty [3, 6-8]. Here, we show that duplication and neofunctionalization of a cytochrome P450, CYP6ER1, led to the evolution of insecticide resistance in the brown planthopper. Considerable genetic variation was observed in the coding sequence of CYP6ER1 in populations of brown planthopper collected from across Asia, but just two sequence variants are highly overexpressed in resistant strains and metabolize imidacloprid. Both variants are characterized by profound amino-acid alterations in substrate recognition sites, and the introduction of these mutations into a susceptible P450 sequence is sufficient to confer resistance. CYP6ER1 is duplicated in resistant strains with individuals carrying paralogs with and without the gain-of-function mutations. Despite numerical parity in the genome, the susceptible and mutant copies exhibit marked asymmetry in their expression with the resistant paralogs overexpressed. In the primary resistance-conferring CYP6ER1 variant, this results from an extended region of novel sequence upstream of the gene that provides enhanced expression. Our findings illustrate the versatility of gene duplication in providing opportunities for functional and regulatory innovation during the evolution of an adaptive trait.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 29337073 · DOI · PMC5788746

Pesticide use negatively affects bumble bees across European landscapes [3]

Research article Nicholson CC, Knapp J, Kiljanek T, Albrecht M, Chauzat MP, Costa C, et al. · · 2024 · cited 106 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Sustainable agriculture requires balancing crop yields with the effects of pesticides on non-target organisms, such as bees and other crop pollinators.
Closing excerpt
These findings support the need for postapproval monitoring of both pesticide exposure and effects to confirm that the regulatory process is sufficiently protective in limiting the collateral environmental damage of agricultural pesticide use.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (190 words)

Sustainable agriculture requires balancing crop yields with the effects of pesticides on non-target organisms, such as bees and other crop pollinators. Field studies demonstrated that agricultural use of neonicotinoid insecticides can negatively affect wild bee species1,2, leading to restrictions on these compounds3. However, besides neonicotinoids, field-based evidence of the effects of landscape pesticide exposure on wild bees is lacking. Bees encounter many pesticides in agricultural landscapes4-9 and the effects of this landscape exposure on colony growth and development of any bee species remains unknown. Here we show that the many pesticides found in bumble bee-collected pollen are associated with reduced colony performance during crop bloom, especially in simplified landscapes with intensive agricultural practices. Our results from 316 Bombus terrestris colonies at 106 agricultural sites across eight European countries confirm that the regulatory system fails to sufficiently prevent pesticide-related impacts on non-target organisms, even for a eusocial pollinator species in which colony size may buffer against such impacts10,11. These findings support the need for postapproval monitoring of both pesticide exposure and effects to confirm that the regulatory process is sufficiently protective in limiting the collateral environmental damage of agricultural pesticide use.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 38030722 · DOI · PMC11006599

Neonicotinoid Levels Exceed EPA Benchmarks in Half of Waterways on Illinois Protected Lands [4]

Research article Hohoff TC, Bilger EE, Gieser R, Davis MA · · 2026

Abstract reading summary — source excerpts
Opening excerpt
Neonicotinoids have become widely used pesticides due to their specificity for insects.
Closing excerpt
This study suggests the high level of contamination found at protected sites is concerning for ecosystem health as insects are the target prey for many wildlife species.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (190 words)

Neonicotinoids have become widely used pesticides due to their specificity for insects. We explored how these contaminants are distributed on protected lands within Illinois. We hypothesized that there would be lower insect biomass at sites with higher neonicotinoid concentrations which we expected to occur at sites with a higher surrounding proportion of agriculture. We predicted that neonicotinoid levels would be highest at the start of the season, coincident with planting, then taper off throughout the growing season. Our results revealed that 25 of 50 sites surveyed had concentrations of at least one neonicotinoid (imidacloprid or clothianidin) over United States Environmental Protection Agency (EPA) benchmarks for chronic exposure. Imidacloprid had high detection above EPA benchmarks in Cook County while clothianidin was more often above benchmarks in central Illinois. There was a negative relationship between clothianidin levels and ratio of agriculture on measured insect biomass at sites with a higher proportion of agriculture. We did not identify a clear peak of imidacloprid or clothianidin concentrations. This study suggests the high level of contamination found at protected sites is concerning for ecosystem health as insects are the target prey for many wildlife species.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 42622890 · DOI · PMC13493470

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Human exposure to neonicotinoid insecticides and the evaluation of their potential toxicity: An overview [5]
    Han W, Tian Y, Shen X · Chemosphere · 2018 · cited 298 times (Europe PMC)
  • Research article A critical review on the potential impacts of neonicotinoid insecticide use: current knowledge of environmental fate, toxicity, and implications for human health [6]
    Thompson DA, Lehmler HJ, Kolpin DW, Hladik ML, Vargo JD, Schilling KE, et al. · Environ Sci Process Impacts · 2020 · cited 256 times (Europe PMC)
  • Research article Neonicotinoids and Other Insect Nicotinic Receptor Competitive Modulators: Progress and Prospects [7]
    Casida JE · Annu Rev Entomol · 2018 · cited 242 times (Europe PMC)
  • Research article Neonicotinoid Insecticides: Molecular Targets, Resistance, and Toxicity [8]
    Matsuda K, Ihara M, Sattelle DB · Annu Rev Pharmacol Toxicol · 2020 · cited 226 times (Europe PMC)
  • Research article Mechanism of Neonicotinoid Toxicity: Impact on Oxidative Stress and Metabolism [9]
    Wang X, Anadón A, Anadón A, Wu Q, Qiao F, Ares I, et al. · Annu Rev Pharmacol Toxicol · 2018 · cited 221 times (Europe PMC)
  • Research article Drivers of colony losses [10]
    Steinhauer N, Kulhanek K, Antúnez K, Human H, Chantawannakul P, Chauzat MP, et al. · Curr Opin Insect Sci · 2018 · cited 214 times (Europe PMC)

References

  1. Manjon C, Troczka BJ, Zaworra M, Beadle K, Randall E, Hertlein G, et al.. Unravelling the Molecular Determinants of Bee Sensitivity to Neonicotinoid Insecticides. . 2018. PMID 29576476 · DOI · PMC5887109
  2. Zimmer CT, Garrood WT, Singh KS, Randall E, Lueke B, Gutbrod O, et al.. Neofunctionalization of Duplicated P450 Genes Drives the Evolution of Insecticide Resistance in the Brown Planthopper. . 2018. PMID 29337073 · DOI · PMC5788746
  3. Nicholson CC, Knapp J, Kiljanek T, Albrecht M, Chauzat MP, Costa C, et al.. Pesticide use negatively affects bumble bees across European landscapes. . 2024. PMID 38030722 · DOI · PMC11006599
  4. Hohoff TC, Bilger EE, Gieser R, Davis MA. Neonicotinoid Levels Exceed EPA Benchmarks in Half of Waterways on Illinois Protected Lands. . 2026. PMID 42622890 · DOI · PMC13493470
  5. Han W, Tian Y, Shen X. Human exposure to neonicotinoid insecticides and the evaluation of their potential toxicity: An overview. Chemosphere. 2018. PMID 29100122 · DOI
  6. Thompson DA, Lehmler HJ, Kolpin DW, Hladik ML, Vargo JD, Schilling KE, et al.. A critical review on the potential impacts of neonicotinoid insecticide use: current knowledge of environmental fate, toxicity, and implications for human health. Environ Sci Process Impacts. 2020. PMID 32267911 · DOI · PMC11755762
  7. Casida JE. Neonicotinoids and Other Insect Nicotinic Receptor Competitive Modulators: Progress and Prospects. Annu Rev Entomol. 2018. PMID 29324040 · DOI
  8. Matsuda K, Ihara M, Sattelle DB. Neonicotinoid Insecticides: Molecular Targets, Resistance, and Toxicity. Annu Rev Pharmacol Toxicol. 2020. PMID 31914891 · DOI
  9. Wang X, Anadón A, Anadón A, Wu Q, Qiao F, Ares I, et al.. Mechanism of Neonicotinoid Toxicity: Impact on Oxidative Stress and Metabolism. Annu Rev Pharmacol Toxicol. 2018. PMID 28968193 · DOI
  10. Steinhauer N, Kulhanek K, Antúnez K, Human H, Chantawannakul P, Chauzat MP, et al.. Drivers of colony losses. Curr Opin Insect Sci. 2018. PMID 29764654 · DOI

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-31.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • NicotineDrugs and Chemicals
  • EndocannabinoidsDrugs and Chemicals
  • Vasoactive Intestinal PeptideDrugs and Chemicals
  • Muscarinic AntagonistsPharmacology
  • beta-EndorphinDrugs and Chemicals
  • MuscimolDrugs and Chemicals

All 546 articles in Drugs and Chemicals →

At a glance

5,794
PubMed records on this heading
54%
published since 2020
160
review articles
74
randomized trials
10
verified references below

Counts come from PubMed on 2026-10-31; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • NicotineDrugs and Chemicals
  • EndocannabinoidsDrugs and Chemicals
  • Vasoactive Intestinal PeptideDrugs and Chemicals
  • Muscarinic AntagonistsPharmacology
  • beta-EndorphinDrugs and Chemicals

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support